| Reference | FOI 2026/1820 |
|---|---|
| Description | FOI Request regarding Type 1 diabetes testing |
| Date Requested | 12/06/2026 |
| Date Replied | 03/07/2026 |
| Category | Medicines Optimisation |
I am writing under the Freedom of Information Act 2000 to request information held by your organisation regarding Type 1 diabetes testing. Please complete this form with the information you have available.
Q1. Do you provide autoantibody testing for diagnosis of Type 1 diabetes?
Q1a. If yes, please indicate which assays are available either onsite or via referral to another laboratory:
Q1b. Does your organisation receive requests for Type 1 diabetes autoantibody testing in individuals without clinically diagnosed diabetes (e.g. screening of at-risk relatives or other asymptomatic individuals)?
☐ Yes
☐ No
☐ Unknown
Q1c. Please provide the number of unique patients tested clinically for the following autoantibodies during:
Please exclude research-only testing where identifiable.
Please provide separate figures for:
If exact patient numbers are not available, please provide the closest available measure (e.g. request numbers or assay volumes) and specify the metric used. Answer table:
| Patients Tested Onsite | Outside Lab | ||
| 2025 (Calendar Year) | GAD only | ||
| Combination of any of GAD, IA-2 and/or ZnT8 | |||
| IAA only (if available)
|
|||
| 1st quarter 2026 (January – March) | GAD only | ||
| Combination of any of GAD, IA-2 and/or ZnT8 | |||
| IAA only (if available) |
Q1d. If an external laboratory is used, please provide:
Q2a. If readily available, please provide the number of unique patients in 2025 and Jan–Mar 2026 who tested positive for:
Please exclude research-only testing where possible.
Q2b. Of the unique patients who tested positive, how many were referred through an early stage/asymptomatic screening programme?
Q3. Please provide the average turnaround time over the last 12 months for Type 1 diabetes autoantibody testing:
1a. Not applicable
1b. No
1c. Not applicable
1d. Not applicable
2a. Not applicable
2b. Not applicable